Goldman Sachs Group Inc Bausch Health Companies Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,443,498 shares of BHC stock, worth $29.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,443,498
Previous 5,385,036 36.05%
Holding current value
$29.2 Million
Previous $37.5 Million 25.23%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$5.22 - $8.26 $10.1 Million - $16 Million
-1,941,538 Reduced 36.05%
3,443,498 $28.1 Million
Q2 2024

Aug 13, 2024
BUY
$6.1 - $10.41 $20.7 Million - $35.4 Million
3,398,277 Added 171.05%
5,385,036 $37.5 Million
Q1 2024

May 15, 2024
BUY
$7.77 - $10.61 $4.05 Million - $5.53 Million
521,198 Added 35.56%
1,986,759 $21.1 Million
Q4 2023

Feb 13, 2024
BUY
$6.53 - $8.23 $863,507 - $1.09 Million
132,237 Added 9.92%
1,465,561 $11.8 Million
Q3 2023

May 14, 2024
SELL
$7.69 - $9.71 $1.02 Million - $1.28 Million
-132,237 Reduced 9.02%
1,333,324 $11 Million
Q3 2023

Nov 14, 2023
SELL
$7.69 - $9.71 $3.25 Million - $4.11 Million
-422,890 Reduced 24.08%
1,333,324 $11 Million
Q2 2023

May 14, 2024
BUY
$5.72 - $8.8 $1.6 Million - $2.46 Million
279,204 Added 18.9%
1,756,214 $14 Million
Q2 2023

Aug 14, 2023
BUY
$5.72 - $8.8 $1.6 Million - $2.46 Million
279,204 Added 18.9%
1,756,214 $14 Million
Q1 2023

May 14, 2024
SELL
$6.28 - $9.85 $53.7 Million - $84.2 Million
-8,543,903 Reduced 85.26%
1,477,010 $12 Million
Q1 2023

May 11, 2023
SELL
$6.28 - $9.85 $53.7 Million - $84.2 Million
-8,543,903 Reduced 85.26%
1,477,010 $12 Million
Q4 2022

May 14, 2024
BUY
$6.09 - $7.93 $46.1 Million - $60.1 Million
7,577,847 Added 310.18%
10,020,913 $62.9 Million
Q4 2022

Feb 13, 2023
BUY
$6.09 - $7.93 $46.1 Million - $60.1 Million
7,577,847 Added 310.18%
10,020,913 $62.9 Million
Q3 2022

May 14, 2024
BUY
$4.58 - $9.21 $2.45 Million - $4.93 Million
535,082 Added 28.04%
2,443,066 $16.8 Million
Q3 2022

Nov 10, 2022
BUY
$4.58 - $9.21 $2.45 Million - $4.93 Million
535,082 Added 28.04%
2,443,066 $16.8 Million
Q2 2022

May 14, 2024
BUY
$7.06 - $23.63 $3.12 Million - $10.5 Million
442,423 Added 30.19%
1,907,984 $16 Million
Q2 2022

Aug 15, 2022
BUY
$7.06 - $23.63 $9.18 Million - $30.7 Million
1,300,031 Added 213.84%
1,907,984 $16 Million
Q1 2022

May 16, 2022
SELL
$21.6 - $27.79 $4.96 Million - $6.39 Million
-229,784 Reduced 27.43%
607,953 $13.9 Million
Q4 2021

Feb 14, 2022
BUY
$23.0 - $29.01 $168,268 - $212,237
7,316 Added 0.88%
837,737 $23.1 Million
Q3 2021

Nov 10, 2021
BUY
$25.04 - $30.06 $20.8 Million - $25 Million
830,421 New
830,421 $23.1 Million

Others Institutions Holding BHC

# of Institutions
255
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email